All questions are shown as received by the Trust.
1. How effective are the current plans in mitigating medication supply chain disruptions?
2. Has the trust had any incidents or patient safety issues related to medication supply disruption in the last 12 months?
3. What does your trust do to manage a potential disruption in medication supplies?
4. Does the shortage of medical supplies affect the clinical decisions related to prescribing practices? If so, what has the trust done to manage or mitigate this?
5. As a Trust, how does your organization evaluate the impact of medication supply chain disruptions and the measures in place to manage them? How often does this occur?
